OptiScan Biomedical

OverviewSuggest Edit

OptiScan Biomedical Corporation has developed an innovative monitoring platform for use in hospital intensive care units (ICU) to support clinicians in detecting changes more rapidly in critically ill patients, enabling more timely intervention. The OptiScanner® platform is presently focused on delivering automated bedside glucose monitoring to support clinicians’ reach and maintain the right level of glucose control.

HQHayward, CA, US
Employee Ratings3.3

Latest Updates

Employees (est.) (Jun 2022)28
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at OptiScan Biomedical

Cary G. Vance

Cary G. Vance

CEO, Director
Patrick Nugent

Patrick Nugent

Jim Causey

Jim Causey

VP of Innovation
Mario P. Cervantes

Mario P. Cervantes

VP Operations
Chip Zimliki

Chip Zimliki

Vice President of Regulatory, Quality, & Clinical Affairs
Show more

OptiScan Biomedical Office Locations

OptiScan Biomedical has an office in Hayward
Hayward, CA, US (HQ)
24590 Clawiter Rd
Show all (1)

OptiScan Biomedical Financials and Metrics

Summary Metrics

Founding Date


OptiScan Biomedical total Funding

$181 m

OptiScan Biomedical latest funding size

$20 m

Time since last funding

3 years ago

OptiScan Biomedical investors

OptiScan Biomedical's latest funding round in March 2019 was reported to be $20 m. In total, OptiScan Biomedical has raised $181 m
Show all financial metrics

OptiScan Biomedical Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

OptiScan Biomedical Online and Social Media Presence

Embed Graph

OptiScan Biomedical Blogs

OptiScan Biomedical Receives CE Mark for OptiScanner ® 7000 for Automated Multivariate Monitoring of Metabolic and Hemodynamic Status of Patients in the Intensive Care Unit

Company Secures EU Certification for First-of-its-Kind Continuous Monitoring System Capable of Assessing and Trending Glucose, Lactate and Scv02 in Single Micro-Sample of Blood Hayward, CA, May 12, 2020 – OptiScan Biomedical Corporation, developer of the only automated, multi-analyte, bedside, conti…

OptiScan Biomedical Announces Peer-Reviewed Publications Highlighting First-of-its-Kind Continuous Monitoring Platform for Intensive Care Units

OptiScanner Continuous Monitoring Platform Demonstrates Ability to Facilitate Enhanced Control of Glucose Levels in Critically Ill Patients, including those in Burn ICU Hayward, CA, December 4, 2019 – OptiScan Biomedical Corporation, a developer of an innovative continuous monitoring system for use …

OptiScan Biomedical Completes $20 Million Series E Financing

Proceeds to Support U.S. Commercialization of OptiScanner 5000 and Ongoing Platform Expansion Company’s First-of-its-Kind Continuous Monitoring Platform for Intensive Care Units to be Highlighted at 39th Annual ISICEM Conference Hayward, CA, March 20, 2019 – OptiScan Biomedical Corporation, a develo…

OptiScan Biomedical Frequently Asked Questions

  • When was OptiScan Biomedical founded?

    OptiScan Biomedical was founded in 1994.

  • Who are OptiScan Biomedical key executives?

    OptiScan Biomedical's key executives are Cary G. Vance, Patrick Nugent and Jim Causey.

  • How many employees does OptiScan Biomedical have?

    OptiScan Biomedical has 28 employees.

  • Who are OptiScan Biomedical competitors?

    Competitors of OptiScan Biomedical include Second Genome, Precise Bio and Winnoz Technology.

  • Where is OptiScan Biomedical headquarters?

    OptiScan Biomedical headquarters is located at 24590 Clawiter Rd, Hayward.

  • Where are OptiScan Biomedical offices?

    OptiScan Biomedical has an office in Hayward.

  • How many offices does OptiScan Biomedical have?

    OptiScan Biomedical has 1 office.